Abstract
Endothelial cells (EC) have long considered a “passive” lining of blood vessels, endowed with negative properties, the most important one being that of representing a non-thrombogenic substrate for blood. As such, EC were viewed to participate in tissue reactions essentially as targets for injurious agents. The possibility of isolating and culturing EC from various tissues gave the tools for studying their complex reactions to a variety of activating stimuli. EC have, in this way emerged as active participants in many physiological and pathological processes. It is now evident that hemostasis, inflammatory reactions, and immunity involve close interactions between immunocompetent cells and vascular endothelium. In particular, the ontogeny and function of white blood cells require an intimate relationship with vascular EC. Cytokines are mediators of these complex bi-directional interactions between leukocytes and vascular elements (for review see Mantovani and Dejana, 1989, Mantovani, Bussolino, and Dejana, 1992).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brown, Z., M.E. Gerritsen, W.W. Carley, R.M. Strieter, S.L. Kunkel, and J. Westwick. Chemokine gene expression and secretion by cytokine-activated human microvascular endothelial cells — Differential regulation of monocyte chemoattractant protein-1 and interleukin-8 in response to interferon-gamma. Am. J. Pathol., 145:913–921, 1994.
Bussolino, F., M. Arese, L. Silvestro, R. Soldi, E. Benfanati, F. Sanavio, M. Aglietta, A. Bosia, and G. Camussi. Involvement of a serine protease in the synthesis of platelet-activating factor by endothelial cells stimulated by tumor necrosis factor-alpha or interleukin-1 alpha. Eur. J. Immunol., 24:3131–3139, 1994a.
Bussolino, F., E. Bocchietto, F. Silvagno, R. Soldi, M. Arese, and A. Mantovani. Actions of molecules which regulate hemopeiesis on endothelial cells: memoirs of common ancestors? Path. Res. Pract., 190:834–839, 1994b.
Bussolino, F., F. Silvagno, G. Garbarino, C. Costamagna, F. Sanavio, M. Arese, R. Soldi, M. Aglietta, G. Pescarmona, G. Camussi, et al. Human endothelial cells are targets for platelet-activating factor (PAF). Activation of alpha and beta protein kinase C isozymes in endothelial cells stimulated by PAF. J. Biol. Chem., 269:2877–2886, 1994c.
Bussolino, F. And G. Camussi. Platelet-activating factor produced by endothelial cells. A molecule with autocrine and paracrine properties. Eur. J. Biochem., 229:327–337, 1995.
Calderon, T.M., J. Sherman, H. Wilkerson, V.B. Hatcher, and J.W. Berman. Interleukin 6 modulates c-sis gene expression in cultured human endothelial cells. Cell Immunol., 143:118–126, 1992.
Camacho, M., Godessart, R. Anton, M. Garcia, and L. Vila. Interleukin-1 enhances the ability of cultured human umbilical vein endothelial cells to oxidize linoleic acid. J. Biol. Chem., 270:17279–17286, 1995.
Cao, Y.H., Chen, J.A. Weatherbee, M. Tsang, and J. Folkman. gro-beta, a-C-X-C-chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice. J. Exp. Med., 182:2069–2077, 1995.
Carvalho, D., C.O.S. Savage, C.M. Blanck, and J.D. Pearson. IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. J. Clin. Invest., 97:111–119, 1996.
Caverth, H.J., J.F. Bohnsack, T.M. McIntyre, M. Baggiolini, S.M. Prescott, and G.A. Zimmerman. Neutrophil activating factor (NAF) induces polymorphonuclear leukocyte adherence to endothelial cells and to subendothelial matrix proteins. Biochem. Biophys. Res. Comm., 162:387–393, 1989.
Chen, C.C. and A.M. Manning. TGF-beta 1, IL-10, and IL-4 differentially modulate the cytokine-induced expression of the IL-6 and IL-8 in human endothelial cells. Cytokine, 8:58–65, 1996.
Chirivi, R.G., M.I. Nicoletti, A. Remuzzi, and R. Giavazzi. Cytokines and cell adhesion molecules in tumor-endothelial cell interaction and metastasis. Cell Adhes. Commun., 2:219–224, 1994.
Chu, W., D.K. Burns, R.A. Swerlick, and D.H. Presky. Identification and characterization of a novel cytokine-inducible nuclear protein from human endothelial cells. J. Biol. Chem., 270:10236–10245, 1995.
Claria, J. and C.N. Serhan. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc. Natl. Acad. Sci. USA, 92:9475–9479, 1995.
Clinton, S.K., J.C. Fleet, H. Loppnow, R.N. Salomon, B.D. Clark, J.G. Cannon, A.R. Shaw, C.A. Dinarello, and P. Libby. Interleukin-1 gene expression in rabbit vascular tissue in vivo. Am. J. Pathol., 138:1005–10014, 1991.
Cobbs, C.S., J.E. Brenman, K.D. Aldape, D.S. Bredt, and M.A. Israel. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res., 55;727–730, 1995.
Colotta, F., M. Sironi, A. Borre, W. Luini, F. Maddalena, and A. Mantovani. Interleukin 4 amplifies monocyte chemotactic protein and interleukin 6 production by endothelial cells. Cytokine, 4;24–28, 1992.
Colotta, F., F. Re, M. Muzio, R. Bertini, N. Polentarutti, M. Sironi, J.G. Giri, S.K. Dower, J.E. Sims, and A. Mantovani. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science, 261:472–475, 1993a.
Colotta, F., M. Sironi, A. Borre, T. Pollicino, S. Bernasconi, D. Boraschi, and A. Mantovani. Type II interleukin-1 receptor is not expressed in cultured edothelial cells and is not involved in endothelial cell activation. Blood, 81:1347–1357, 1993b.
Colotta, F., F.L. Sciacca, M. Sironi, W. Luini, M.J. Rabiet, and A. Mantovani. Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. Am. J. Pathol., 144:975–985, 1994.
Colotta, F., S. Orlando, E.J. Fadlon, S. Sozzani, C. Matteucci, and A. Mantovani. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells. J. Exp. Med., 181:2181–2188,1995.
Coulpier, M., S. Andreev, C. Lemercier, H. Dauchel, O. Lees, M. Fontaine, and J. Ripoche. Activation of the endothelium by IL-1 alpha and glucocorticoids results in major increase of complement C3 and factor B production and generation of C3a. Clin. Exp. Immunol, 101:142–149, 1995.
Cushing, S.D., J.A. Berliner, A.J. Valente, M.C. Territo, M. Navab. F. Parhami, R. Gerrity, C.J. Schwartz, and A.M. Fogelman. Minimally modified low density lipoprotein induces monocyte chemtactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. USA, 87:5134–5138, 1990.
d’Aniello, E.M., F. Brevario, I. Martin Padura, M.G. Lampugnani, E. Dejana, A. Mantovani, and M. Introna. Interleukin-1 and tumor necrosis factor induce transient expression of an inhibitor of nuclear factor kB in endothelial cells. Endothlelium, 1:161–165, 1993.
De Caterina, R., P. Libby, H.B. Peng, V.J. Thannickal, T.B. Rajavashisth, M.A.J. Gimbrone, W.S. Shin, and J.K. Liao. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectivity reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest., 96:60–68, 1995.
de Martin, R., B. Vanhove, Q. Cheng, E. Hofer, V. Csizmadia, H. Winkler, and F.H. Bach. Cytokine-inducible expression in endothelial cells of and I kappa B alpha-like gene is regulated by NF kappa B. EMBO J., 12;2773–2779, 1993.
Debeaux, A.C., J.P. Maingay, J.A. Ross, K.C.H. Fearon, and D.C. Carter. Interleukin-4 and interleukin-10 increase endotoxin-stimulated human umbilical vein endothelial cell interleukin-8 release. J. Interferon. Cytokine Res., 15:441–445, 1995.
Del Papa, N., L. Guidali, M. Sironi, Y. Shoenfeld, A. Mantovani, A. Tincani, G. Balestrier, A. Radice, R.A. Sinico, and P.L. Meroni. Anti-endothelial IgG antibodies from Wegener’s granulomatosis bind to endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum, (In Press).
Devergne, O., A. Marfaingkoka, T.J. Schall, M.B. Legerravet, M. Sadick, M. Peuchmaur, M.C. Crevon, K.J. Kim, P. Galanaud, and D. Emilie. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: Involvement of macrophages and endothelial cells (vol 180, pg 1689, 1994), J. Exp. Med., 180:775, 1994.
Dickson, K., A. Philip, H. Warshawsky, M. O’Connor McCourt, and J.J. Bergeron. Specific binding of endocrine transforming growth factor-beta 1 to vascular endothelium. J. Clin. Invest., 95:2539–2554, 1995.
Dixit, V.M., S. Green, V. Sarma, L.B. Holzman, F.W. Wolf, K. O’Rourke, P.A. Ward, E.V. Prochownik, and R.M. Marks. Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J. Biol Chem., 265:2973–2978, 1990.
Eissner, G., F. Kohlhuber, M. Grell, M. Ueffing, P. Scheurich, A. Hieke, G. Multhoff, G.M. Bornkamm, and E. Holler. Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endoxin. Blood, 86:4184–4193, 1995.
Emsley, J., H.E. White, B.P. O’Hara, G. Oliva, N. Srinivasan, I.J. Tickle, T.L. Blundell, M.B. Pepys, and S.P. Wood. Structure of pentameric human serum amyloid P component. Nature, 367:338–345, 1994.
Ezekowitz, R.A., J.B. Mulliken, and J. Folkman. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy [see comments] [published errata appear in N. Engl. J. Med., 1994, Jan 27:330(4):300 and 1995 Aug 31:333(9):595–6]. N. Engl. J. Med, 326:1456–1463, 1992.
Fan, J., H.Z. Bass, and J.L. Fahey. Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection. J. Immunol., 151:5031–5040, 1993.
Fan, S.T., K. Hsia, and T.S. Edgington. Upregulation of human immunodeficiency virus-1 in chronically infected monocytic cell line by both contact with endothelial cells and cytokines. Blood, 84:1567–1572, 1994.
Faruqi, R., C. de la Motte, and P.E. DiCorleto. Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J. Clin. Invest., 94:592–600, 1994.
Fauci, A.S., B.F. Haynes, and P. Katz. The spectrum of vasculitis. Ann. Intern. Med., 89(Part 1):660–676, 1978.
Fiorelli, V., R. Gendelman, F. Samaniego, P.D. Markham, and B. Ensoli. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi’s sarcoma spindle cells. J. Clin. Invest., 95:1723–1734, 1995.
Fossiez, F., O. Djossou, P. Chomarat, L. Flores-Romo, S. Ait-Yahia, C. Maat, J.J. Pin, P. Garrone, E. Garcia, S. Saelalnd, D. Blanchard, C. Gaillard, B.D. Mahapatra, E. Rouvier, P. Goldstein, J. Banchereau, and S. Lebecque. T-cell IL-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med., (In Press).
Fukuo, K., T. Inoue, S. Morimoto, T. Nakaashi, O. Yasuda, S. Kitano, R. Sasada, and T. Ogihara. Nitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells. A possible mechanism of neovascularization in atherosclerotic plaques. J. Clin. Invest., 95:669–676, 1995.
Galea, P., G. Thibault, M. Lacord, P. Bardos, and Y. Lebranchu. IL-4, but not tumor necrosis factor-alpha, increases endothelial cell adhesiveness for lymphocytes by activating a cAMP-dependent pathway. J. Immunol., 151:588–596,1993.
Gamble, J.R. and M.A. Vadas. Endothelial cell adhesiveness for human T lymphocytes is inhibited by transforming growth factor beta-1. J. lmmunol., 146:1149–1154, 1991.
Ghersa, P., R. Hooft van Huijsduijnen, J. Whelan, Y. Cambet, R. Pescini, and J.F. DeLamarter. Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway. J. Biol. Chem., 269:29129–29137, 1994.
Gimbrone, M.A.J., M.S. Obin, A.F. Brock, E.A. Luis, P.E. Hass, C.A. Hebert, Y.K. Yip, D.W. Leung, D.G. Lowe, W.J. Kohr, W.C. Darbonne, K.B. Bechtol, and J.B. Baker. Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. Science, 246:1601–1603, 1989.
Goldblum, S.E., T. W. Brann, X. Ding, J. Pugin, and P.S. Tobias. Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function, in vitro. J. Clin. Invest., 93:692–702, 1994.
Grell, M., E. Douni, H. Wajant, M. Löheden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kolias, K. Pfizenmaier, and P. Scheurich. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell, 83:793–802, 1995.
Grimm, S. and P.A. Baeuerle. The inducible transcription factor NF-kappa B: structure-function relationship of its protein subunits. Biochem. J., 290:297–308, 1993.
Grosset, C., B. Jazwiec, J.L. Taupin, H. Liu, S. Richard, F.X. Mahon, J. Reiffers, J.F. Moreau, and J. Ripoche. In vitro biosynthesis of leukemia inhibitory factor/human interleukin for DA cells by human endothelial cells: differential regulation by interleukin-1 alpha and glucocorticoids. Blood, 86:3763–3770, 1995.
Gómez-Chiarri, M., T.A. Hamilton, J. Egido, and S.N. Emancipator. Expression of IP-10, a lipopolysaccharide-and interferon-gamma-inducible protein, in murine mesangial cells in culture. Am. J. Pathol., 142:433–439, 1993.
Hadley, T.J., Z.H. Lu, K. Wasniowska, A.W. Martin, S.C. Peiper, J. Hesselgesser, and R. Horuk. Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen. J. Clin. Invest., 94:985–991, 1994.
Hamanaka, R., K. Kono, T. Seguchi, K. Okamura, A. Morimoto, M. Ono, J. Ogata, and M. Kuwano. Induction of low density lipoprotein receptor and a transcription factor SP-1 by tumor necrosis in human microvascular endothelial cells. J. Biol. Chem., 267:13160–13165, 1992.
Haziot, A., G.W. Rong, J. Silver, and S.M. Goyert. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J. Immunol., 151:1500–1507, 1993.
Hebert, C.A., F.W. Luscinskas, J.M. Keily, E.A. Luis, W.C. Darbonne, G.L. Bennet, C.C. Liu, M.S. Obin, M.A.J. Gimbrone, and J.B. Baker. Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophils. J. Immunol., 145:3033–3040, 1990.
Hechtman, D.H., M.I. Cybulsky, H.J. Fuchs, J.B. Baker, and M.A.J. Gimbrone. Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J. Immunol., 147:883–892, 1991.
Heinrich, J.N., R.P. Ryseck, H. Macdonald-Bravo, and R. Bravo. The product of a novel growth factor-activated gene, fic, is a biologically active C-C-type cytokine. Mol. Cell Biol., 13:2020–2030, 1993.
Heller, R., F. Bussolino, D. Ghigo, G. Garbarino, G. Pescarmona, U. Till, and A. Bosia. Human endothelial cells are target for platelet-activating factor II. Platelet activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells. J. Immunol., 149:3682–3688, 1992.
Hill, M.E., I.N. Bird, R.H. Daniels, M.A. Elmore, and M.J. Finnen. Endothelial cell-associated platelet-activating factor primes neutrophils for enhanced Superoxide production and arachidonic acid release during adhesion to but not transmigration across IL-1 beta-treated endothelial monolayers. J. Immunol., 153:3673–3683, 1994.
Hla, T. and T. Maciag. An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J. Biol. Chem., 265:9308–9313, 1990.
Hollenbaugh, D., N. Mischel Petty, C.P. Edwards, J.C. Simon, R.W. Denfeld, P.A. Kiener, and A. Aruffo. Expression of functional CD40 by vascular endothelial cells. J. Exp. Med., 182:33–40, 1995.
Holzman, L.B., R.M. Marks, and V.M. Dixit. A novel immediate-early response gene of endothelium is induced by cytokines and encodes a secreted protein. Mol. Cell Biol., 10:5830–5838, 1990.
Hooft van Huijsduijnen, R., R. Pescini, and J.F. DeLamarter. Two distinct NF-kappa B complexes differing in their larger subunit bind the E-selectin promoter kappa B element. Nucleic Acids Res., 21:3711–3717, 1993.
Hooper, W.C., D.J. Phillips, M.J. Ribeiro, J.M. Benson, V.G. George, E.W. Ades and B.L. Evatt. Tumor necrosis factor-alpha downregulates protein S secretion in human microvascular and umbilical vein endothelial cells but not in the HepG-2 hepatoma cell line. Blood, 84:483–489, 1994.
Howell, G., P. Pham, D. Taylor, B. Foxwell, and M. Feldmann. Interleukin 4 induces interleukin 6 production by endothelial cells: synergy with interferon-gamma. Eur. J. Immunol., 21:91–101, 1991.
Huber, A.R., S.L. Kunkel, R.F. Todd, and S.J. Weiss. Regulation of transendothelial neutrophil migration by endogenous inerleukin-8. Science, 254:99–102, 1991.
Iademarco, M.F., J.J. McQuillan, G.D. Rosen, and D.C. Dean. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J. Biol. Chem., 267:16323–16329, 1992.
Inoue, N., R.C. Venema, H.S. Sayegh, Y. Ohara, T.J. Murphy, and D.G. Harrison. Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-beta 1. Arterioscl. Thromb. Vasc. Biol., 15:1255–1261,1995.
Introna, M., F. Breviario, E. D’Aniello, J. Golay, E. Dejana, and A. Mantovani. Il-1 inducible genes in human umbilical vein endothelial cells. Eur. Heart J., 14(suppl K):78–81, 1993.
Introna, M., V. Vidal Alles, M. Castellano, G. Picardi, L. De Gioia, B. Bottazzi, G. Peri, F. Breviario, M. Salmona, L. De Gregorio, T.A. Dragani, N. Srinivasan, T.L. Blundell, T.A. Hamilton, and A. Mantovani. Cloning of mouse PTX3, a new member of the pentraxin gene family expressed at extrahepatic sites. Blood, 87:1862–1872, 1996.
Jackson, B.A., R.H. Goldstein, R. Roy, M. Cozzani, L. Taylor, and P. Polgar. Effects of transforming growth factor beta and interleukin-1 beta on expression of cyclooxygenase 1 and 2 phospholipase A2 mRNA in lung fibroblasts and endothelial cells in culture. Biochem. Biophys. Res. Commun., 197:1465–1474, 1993.
Jeannin, P., Y. Delneste, P. Gosset, S. Molet, P. Lassale, Q. Hamid, A. Tsicopoulos, and A.B. Tonnel. Histamine induces interleukin-8 secretion by endothelial cells. Blood, 84:2229–2233, 1994.
Jones, K., C. Rivera, C. Sgadar, J. Franklin, E.E. Max, K. Bhatia, and G. Tosato. Infection of human endothelial cells with Epstein-Barr virus. J. Exp. Med., 182:1213–1221, 1995.
Kamijo, R., H. Harada, T. Matsuyama, M. Bosland, J. Gerecitano, D. Shapiro, J. Le, S.I. Koh, T. Kimura, S.J. Green, et al. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science, 263:1612–1615, 1994.
Kaplanski, G., R. Porat, K. Aiura, J.K. Erban, J.A. Gelfand, and C.A. Dinarello. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. Blood, 81:2492–2495, 1993b.
Kaplanski, G., C. Farnarier, S. Kaplanski, R. Porat, L. Shapiro, P. Bongrand, and C.A. Dinarello. Interleukin-1 induces interleukin-8 secretion from endothelial cells by juxtacrine mechanism. Blood, 84:4242–4248, 1994.
Kaplanski, G., N. Teysseire, C. Farnarier, S. Kaplanski, J.C. Lissitzky, J.M. Durand, J. Soubeyrand, C. Dinarello, and P. Bongrand. IL-6 and IL-8 production from cultured human endothelial cells stimulated by infection with Rickettsia conorii a cell-associated IL-1-alpha-dependent pathway. J. Clin. Invest., 96:2839–2844, 1995.
Karakurum, M., R. Shreeniwas, J. Chen, D. Pinsky, S.D. Yan, M. Anderson, K. Sunouchi, J. Major, T. Hamilton, K. Kuwabara, A. Rot, P.R. Nowygrod, and D. Stern. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J. Clin. Invest., 93:1564–1570, 1994.
Karmann, K., C.C. Hughes, J. Schechner, W.C. Fanslow, and J.S. Pober. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. USA, 92:4342–4346, 1995.
Kaszubska, W., R.H. van Huijsduijnen, P. Ghersa, A.M. DeRaemy Schenk, B.P. Chen, T. Hai, J.F. DeLamarter, and J. Whelan. Cyclic AMP-independent ATF family members interact with NF-kappa B and function in the activation of the E-selectin promoter in response to cytokines. Mol. Cell Biol., 13:7180–7190, 1993.
Kilgore, K.S., J.P. Shen, B.F. Miller, P.A. Ward, and J.S. Warren. Ehancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1. J. Immunol., 155:1434–1441, 1995.
Koch, A.E., P.J. Polverini, S.L. Lunkel, L.A. Harlow, L.A. DiPietro, V.M. Einer, S.G. Einer, and R.M. Strieter. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science, 258:1798–1801, 1992.
Korpelainen, E.I., J.R. Gamble, W.B. Smith, G.J. Goodall, S. Qiyu, J.M. Woodcock, M. Dottore, M.A. Vadas, and A.F. Lopez. The receptor for interleukin 3 is selectively induced in human endothelial cells by tumor necrosis factor alpha and potentiates interleukin 8 secretion and neutrophil transmigration. Proc. Natl. Acad. Sci. USA, 90:11137–11141, 1993.
Korpelainen, E.I., J.R. Gamble, W.B. Smith, M. Dottore, M.A. Vadas, and A.F. Lopez. Interferon-gamma upregulates interleukin-3 (IL-3) receptor expression in human endothelial cells and synergizes with IL-3 in stimulating major histocompatability complex class II expression and cytokine production. Blood, 86:176–182, 1995.
Krakauer, T. IL-10 inhibits the adhesion of leukocytic cells to IL-1-activated human endothelial cells. Immunol. Lett., 45:61–65, 1995.
Lamas, S., T. Michel, T. Collins, B.M. Brenner, and P.A. Marsden. Effects of interferon-gamma on nitric oxide synthase activity and endothelial-production by vascular endothelial cells. J. Clin. Invest., 90:879–887, 1992.
Ledebur, H.C. and T.P. Parks. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells — Essential roles of a variant NF-kappa B site and p65 homodimers. J. Biol. Chem., 270:933–943, 1995.
Lee, T.H., G.W. Lee, E.B. Ziff, and J. Vilcek. Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts. Mol. Cell Biol., 10:1982–1988, 1990.
Lewis, H., W. Kaszubska, J.F. DeLamarter, and J. Whelan. Cooperatively between two NF-kappa B complexes, mediated by high-mobility-group protein I(Y), is essential for cytokine-induced expression of the E-selectin promoter. Mol. Cell Biol., 14:5701–5709, 1994.
Ley, K. J.B. Baker, M.I. Cybulsky, M.A. Gimbrone, and F.W. Luscinskas. Intravenous interleukin-8 inhibits granulocyte emigration from rabbit messenteric venules without altering L-selectin expression or leukocyte rolling. J. Immunol., 151:6347–6357, 1993.
Libby, P. and G.K. Hannson. Biology of Disease. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab. Invest., 64:5–15, 1991.
Lienard, D., P. Ewalenko, J.J. Delmotte, N. Renard, and F.J. Lejeune. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J. Clin. Oncol, 10:52–60, 1992.
Liuzzo, G., L.M. Biasucci, J.R. Gallimore, R.L. Grillo, A.G. Rebuzzi, M.B. Pepys, and A. Maseri. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angine [see comments]. N. Engl. J. Med., 1994.
Lukacs, N.W., R.M. Strieter, V. Einer, H.L. Evanoff, M.D. Burdick, and S.L. Kunkel. Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte endothelial cell interactions. Blood, 86:2767–2773, 1995.
Luster, A.D., S.M. Greenberg, and P. Leder. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J. Exp. Med., 182:219–231, 1995.
Mackay, F., H. Loetscher, D. Stueber, G. Gehr, and W. Lesslauer. Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cell is under dominant control of one TNF receptor type, TNF-R55. J. Exp. Med., 177:1277–1286, 1993.
Maier, J.A., P. Voulalas, D. Roeder, and T. Maciag. Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer. Science, 249:1570–1574, 1990.
Maier, J.A., M. Statuto, and G. Ragnotti. Endogenous interleukin-1 alpha must be transported to the nucleus to exert its activity in human endothelial cells. Mol. Cell Biol., 14:1845–1851, 1994.
Maione, T.E., G.S. Gray, J. Petro, A.J. Hunt, A.L. Donner, S.I. Bauer, H.F. Carson, and R.J. Sharpe. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science, 247:77–79, 1990.
Mantovani, A., P. Allavena, F. Collotta, and S. Sozzani. Chemokines in vascular pathophysiology. In: Immune functions of the vassal wall. G.K. Hansson and P. Libby, eds, Harwood Academic Publishers, 1996.
Mantovani, A., F. Bussolino, and E. Dejana. Cytokine regulation of endothelial cell function. FASEB J., 6:2591–2599, 1992.
Mantovani, A. and E. Dejana. Cytokines as communication signals between leukocytes and endothelial cells. Immunol. Today, 10:370–375, 1989.
Marfaingkoka, A., O. Devergne, G. Gorgone, A. Portier, T.J. Schall, P. Galanaud, and D. Emilie. Regulation of the production of the RANTES chemokine by endothelial cells — Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J. Immunol, 154:1870–1878, 1995.
Martin, E. C. Nathan, and Q.W. Xie. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med., 180:977–984, 1994.
Marui, N., M.K. Offermann, R. Swerlick, C. Kunsch, C.A. Rosen, M. Ahmad, R.W. Alexander, and R.M. Medford. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through and antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest., 92:1866–1874, 1993.
Mattila, P., M.L. Majuri, S. Tiisala, and R. Renkonen. Expression of six protein kinase C isotypes in endothelial cells. Life Sci., 55:1253–1260, 1994.
McCarron, R.M., L. Wang, D.B. Stanimirovic, and M. Spatz. Differential regulation of adhesion molecule expression by human cerebrovascular and umbilical vein endothelial cells. Endothelium, 2;339–346, 1995.
Meacock, S., R. Pescini Gobert, J.F. DeLamarter, and R. Hooft van Huijsduijnen. Transcription factor induced, phased bending of the E-selectin promoter. J. Biol. Chem., 269:31756–31762, 1994.
Meininger, C.J., S.E. Brightman, K.A. Kelly, and B.R. Zetter. Increased stem cell factor release by hemangiomaderived endothelial cells. Lab Invest., 72:166–173, 1995.
Meyrick, B., B. Christman, and G. Jesmok. Effects of recombinant tumor necrosis factor-alpha on cultured pulmonary artery and lung microvascular endothelial monolayers. Am. J. Pathol., 138;93–101, 1991.
Miyaloto, S. M. Maki, M. J. Schmitt, M. Hatanaka, and I.M. Verna. Tumor necrosis factor alpha-induced phosphorylation of IkB alpha is a signal for its degradatioin but not dissociation from NF-kB. Proc. Natl. Acad. Sci. USA, 91:12740–12744, 1994.
Montrucchio, G., E. Lupia, E. Battaglia, G. Passerini, F. Bussolino, G. Emanuelli, and G. Camussi. Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J. Exp. Med., 180:377–382, 1994.
Moyer, C.F., D. Sajuthi, H. Tulli, and J.K. Williams. Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis. Am. J. Pathol., 138:951–960, 1991.
Murata, J., S.B. Corradin, E. Felley Bosco, and L. Juillerat Jeanneret. Involvement of a transforming-growth-factor-beta-like molecule in tumor-cell-derived inhibition of nitric oxide synthesis in cerebral endothelial cells. Int. J. Cancer, 62:743–748, 1995.
Narumi, S., L.M. Wyner, M.H. Stoler, C.S. Tannebaum, and T.A. Hamilton. Tissue-specific expression of murine IP-10 mRNA following systematic treatment with interferon-gamma. J. Leukoc. Biol., 52:27–33, 1992.
Nathan, C. and Q.W. Xie. Nitric oxide synthases: roles, tolls, and controls. Cell, 78:915–918, 1994.
Neish, A.S., A.J. Williams, H.J. Palmer, M.Z. Whitley, and T. Collins. Functional analysis of the human vascular cell adhesion molecule 1 promoter. J. Exp. Med., 176:1583–1593, 1992.
Neish, A.S., M.A. Read, D. Thanos, R. Pine, T. Maniatis, and T. Collins. Endothelial interferon regulatory factor 1 cooperates with NF-kB as a transcriptional activator of vascular cell adhesion molecule 1. Mol. Cell Biol., 15:2558–2569, 1995.
Nelken, N.A., S.R. Coughlin, D. Gordon, and J.N. Wilcox. Monocyte chemoattractant protein-1 in human atheromatous plaques. J. Clin. Invest., 88:1121–1127, 1991.
Niedbala, M. J. and M. Stein Picarella. Role of protein kinase C in tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator. Blood, 81:2608–2617, 1993.
Niu, X.F., C.W. Smith, and P. Kubes. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ. Res., 74:113–1140, 1994.
Noland, T.D., B.B. Friday, M.T. Maulit, and G.L. Gerton. The sperm acrosomal matrix contains a novel member of the pentraxin family of calcuim-dependent binding proteins. J. Biol. Chem., 269:32607–32614, 1994.
Opipari, A.W.J., H.M. Hu, R. Yabkowitz, and V.M. Dixit. The A20 zinc finger protein protects cells from tumor necrosis factor cytotooxicity. J. Biol. Chem., 267:12424–12427, 1992.
Oswald, I.P., I. Eltoum, T.A. Wynn, B. Schwartz, P. Caspar, D. Paulin, A. Sher, and S.L. James. Endothelial cells are activated by cytokine treatment to kill an intravascular parasite, Schistosoma mansoni, through the production of nitric oxide. Proc. Natl. Acad. Sci. USA, 91:999–1003, 1994.
Paleolog, E.M., S.A. Delasalle, W.A. Buurman, and M. Feldmann. Functional activities of receptors for tumor necrosis factor-alpha on human vascular endothelial cells. Blood, 84:2578–2590, 1994.
Palmercrocker, R.L. and J.S. Pober. IL-4 induction of VCAM-1 on endothelial cells involves activation of a protein tyrosine kinase. J. Immunol., 154:2838–2845, 1995.
Pandey, A., H. Shao, R.M. Marks, P.J. Polverini, and V.M. Dixit. Role of B61, the ligand for the Eck tyrosine kinase in TNF-alpha-induced angiogenesis. Science, 268,567–569, 1995.
Parry, G.C. and N. Mackman. A set of inducible genes expressed by activated human monolytic and endothelial cells contain kappa B-like sites that specifically bind c-Rel-p65 heterodimers. J. Biol. Chem., 269:20823–20825, 1994.
Patel, K.D., V. Modur, G.A. Zimmerman, S.M. Prescott, and T.M. McIntyre. The necrotic venom of the brown recluse spider induces dysregulated endothelial cell-dependent neutrophil activation — Differential induction of GM-CSF, IL-8, and E-selectin expression. J. Clin. Invest., 94:631–642, 1994.
Pattison, J., P.J. Nelson, P. Huie, I. Vonleuttichau, G. Farshid, R.K. Sibley, and A.M. Kresky. RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet, 343:209–211, 1994.
Peiper, S.C., Z.X. Wang, K. Neote, A.W. Martin, H.J. Showeil, M.J. Conklyn, K. Ogborne, T.J. Hadley, Z.H. Lu, J. Hesselgesser, and R. Horuk. The Duffy antigen receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J. Exp. Med.,181:1311–1317,1995.
Peng, H.B., P. Libby, and J.K. Liao. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J. Biol. Chem., 270:14214–14219, 1995.
Peng, H.B., T.B. Rajavashisth, P. Libby, and J.K. Liao. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J. Biol. Chem., 270:17050–17055, 1995.
Pepys, M.B. and M.L. Baltz. Actue phase proteins with special reference to C-reactive protein and related proteins (pentaxis) and serum amyloid A protein. Adv. Immunol., 34:141–160, 1983.
Pescini, R., W. Kaszubska, J. Whelan, J.F. DeLamarter, and R. Hooft van Huijsduijnen. ATF-a0, a novel variant of the ATF/CREB transcription factor family, forms a dominant transcription inhibitor in ATF-a heterodimers. J. Biol. Chem., 269:1159–1165, 1994.
Petzelbauer, P., J.R. Bender, J. Wilson, and J.S. Pober. Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. J. Immunol., 151:5062–5072, 1993.
Petzelbauer, P., C.A. Watson, S.E. Pfau, and J.S. Pober. Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. J. Immunol., 151:5062–5072, 1993.
Pober, J. and R.S. Cotran. Cytokines and endothelial cell biology. Physiol. Rev., 70:427–451, 1990.
Pober, J.S. M.R. Slowik, L.G. De Luca, and A.J. Ritchie. Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. J. Immunol, 150:5114–5123, 1993.
Pugin, J., C.C. Schurer Maly, D. Leturcq, A. Moriarty, R.J. Ulevitch, and P.S. Tobias. Lipopolysaccharide activation of human endothelial and epithelial cells is medicated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA, 90:2744–2478, 1993.
Pugin, J., R.J. Ulevitch, and P.S. Tobias. A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation. J. Exp. Med., 178:2193–2200, 1993.
Qi, J.F. and D.L. Kreutzer. Fibrin activation of vascular endothelial cells — Induction of IL-8 expression. J. Immunol, 155:867–876, 1995.
Radomski, M.W., R.M. Palmer, and S. Moncada. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. USA, 87:10043–10047, 1990.
Rajavashisth, T.B., A. Andalibi, M.C. Territo, J.A. Berliner, M. Navab, A.M. Fogelman, and A.J. Lusis. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature, 344:254–257, 1990.
Read, M.A., S.R. Cordle, R.A. Veach, C.D. Carlisle, and J. Hawiger. Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells. Proc. Natl. Acad. Sci. USA, 90:9887–9891, 1993.
Read, M.A., M.Z. Whitley, A.J. Williams, and T. Collins. NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation. J. Exp. Med., 179:503–512, 1994.
Reid, M.S. and C.P. Blobel. Apexin, and acrosomal pentaxin. J. Biol. Chem., 269:32615–32620, 1994.
Remzzi, G. and P. Ruggenenti. The hemolytic uremic syndrome. Kidney Int., 48:2–19, 1995.
Ritchie, A.J., D.R. Johnson, B.M. Ewenstein, and J.S. Pober. Tumor necrosis factor induction of endothelial cell surface antigens is independent of protein kinase C activation or inactivation. Studies with phorbol myristate acetate and staurosporine. J. Immunol., 146:3056–3062, 1991.
Rollins, B.J., T. Yoshimura, E.J. Leonard, and J.S. Pober. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am. J. Pathol., 136:1229–1233, 1990.
Rollins, B.J. and J.S. Pober. Interleukin-4 induces the synthesis and secretion of MCP-1JE by human endothelial cells. Am. J. Pathol., 138:1315–1319, 1991.
Romer, L.H., N.V. McLean, H.C. Yan, M. Daise, J. Sun, and H.M. DeLisser. IFN-gamma and TNF-alpha induce redistribution of PECAM-1 (CD31) on human endothelial cells. J. Immunol., 154:6582–6592. 1995.
Rosenkrantz Weiss, P., W.C. Sessa, S. Milstien, S. Kaufman, C.A. Watson, and J.S. Pober. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetra-hydrobiopterin levels enhance endothelial nitric oxide synthase specific activity [see comments]. J. Clin. Invest., 93:2236–2243, 1994.
Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 362:801–809, 1993.
Rossi, V., F. Brevario, P. Ghezzi, E. Dejana, and A. Mantovani. Prostacyclin synthesis induced in vascular cells by ineterleukin-1. Science, 229:174–176, 1985.
Rot, A. Endothelial cell binding of NAP-1/IL-8: role of neutrophil emigration. Immunol. Today, 13:291–294, 1992.
Rott, O., U. Tontsch, B. Fleischer, and E. Cash. Interleukin-6 production in “normal” and HTLV-1 tax-epressing brain specific endothelial cells. Eur. J. Immunol., 23:1987–1991, 1993.
Rovin, B.H., T. Yoshimura, and L. Tan. Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J. Immunol., 148:2148–2153, 1992.
Saadi, S., R.A. Holznecht, C. Patte, D.M. Stern, and J.L. Platt. Complement-mediated regulation of tissue factor activity in endothelium. J. Exp. Med., 182:1807–1814, 1995.
Sakurai, H., Kohsaka, M.F. Liu, H. Higashiyama, Y. Hirata, K. Kanno, I. Saito, and N. Miyasaka. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J. Clin. Invest., 96:2357–2363, 1995.
Samaniego, F., P.D. Markham, R.C. Gallo, and B. Ensoli. Inflammatory cytokines induce AIDS-Kaposi’s sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi’s sarcoma-like lesion formation in nude mice. J. Immunol, 154:3582–3592, 1995.
Sankar, S., N. Mahooti Brooks, M. Centrella, T.L. McCarthy, and J.A. Madri. Expression of transforming growth factor type III receptor in vascular endothelial cells increases their responsiveness to transforming growth factor beta 2. J. Biol. Chem., 270:13567–13572, 1995.
Sarma, V., F.W. Wolf, R.M. Marks, T.B. Shows, and V.M. Dixit. Cloning of a novel tumor necrosis factor-alpha-inducible primary response gene that is differentially expressed in development and capillary tube-like formation in vitro. J. Immunol, 148:3302–3312, 1992.
Sato, K., K. Miyakawa, M. Takeya, R. Hattori, Y. Yui, M. Sunamoto, Y. Ichimori, Y. Ushio, and K. Takahashi. Immunohistochemical expression of inducible nitric oxide synthase (iNOS) in reversible endotoxic shock studied by a novel monoclonal antibody against rat iNOS. J. Leukoc. Biol., 57:36–44, 1995.
Satriano, J.A., K. Hora, Z. Shan, E.R. Stanley, T. Mori, and D. Schlondorff. Regulation of monocyte chemoatttarctant protein-1 and macrophage colony-stimulating factor-1 by IFN-gamma, tumor necrosis factor-alpha, IgG aggregates, and cAMP in mouse mesangial cells. J. Immunol, 150:1971–1978, 1993a.
Satriano, J.A., M. Shuldiner, K. Hora, Y. Xing, Z. Shan, and D. Schlondorff. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin-G-evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J. Clin. Invest., 92:1564–1571, 1993b.
Schieven, G.G., J.C. Kallestad, T.J. Brown, J.A. Ledbetter, and P.S. Linsley. Oncostatin M induces tyrosine phosphorylation in endothelial cells and activation of p62yes tyrosine kinase. J. Immunol, 149:1676–1682, 1992.
Schindler, U. and V.R. Baichwal. Three NF-kappa B binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression. Mol. Cell Biol., 14:5820–5831, 1994.
Schlimgen, A.K., J.A. Helms, H. Vogel, and M.S. Perin. Neuronal pentraxin, a secreted protein with homology to acute phase proteins of the immune system. Neuron., 14:519–526, 1995.
Schmid, E.F., K. Binder, M. Grell, P. Scheurich, and K. Pfizenmaier. Both tumor necrosis factor receptors, TNFR60 and TNFR80 are involved in a signaling endothelial tissue factor expression by juxtacrine tumor necrosis factor alpha. Blood, 86:1836–1841, 1995.
Schoedon, G., M. Schneemann, N. Blau, C.J. Edgell, and A. Schaffner. Modulation of human endothelial cell tetrahydrobiopterin synthesis by activating and deactivation cytokines: new perspectives on endothelium-derived relaxing factor. Biochem. Biophys. Res. Commun., 196:1343–1348, 1993.
Schofield, L., S. Novakovic, P. Gerold, R.T. Schwartz, M.J. McConville, and S.D. Tachado. Glycosylphosphatidylinositol toxin of plasmodium upregulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction. J. Immunol, 156:1886–1896, 1996.
Schonbeck, U., E. Brandt, F. Petersen, H.D. Flad, and H. Loppnow. IL-8 specifically binds to endothelial but not to smooth muscle cells. J. Immunol, 154:2375–2383, 1995.
Schroder, J.M. and E. Christophers. Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells. J. Immunol, 142:244–251, 1989.
Schultz, R., D.L. Panas, R. Catena, S. Moncada, P.M. Olley, and G.D. Lopaschuk. The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumor necrosis factor-alpha. Br. J. Pharmacol, 114:27–34, 1995.
Schwartz, D., A. Andalibi, L. Chaverrialmada, J.A. Berliner, T. Kirchgessner, Z.T. Fang, P. Tekampolson, A.J. Lusis, C. Gallegos, A.M. Fogelman, and M.C. Territo. Role of the GRO family of chemokines in monocyte adhesion to MM-LDL-stimulated endothelium. J. Clin. Invest., 94:1968–1973, 1994.
Shu, H.B., A.B. Agranoff, E.G. Nabel, K. Leung, C.S. Duckett, A.S. Neish, T. Collins, and G.J. Nabel. Differential regulation of vascular cell adhesion molecule 1 gene expression by specific NF-kappa B subunits in endothelial and epithelial cells. Mol. Cell Biol., 13:6283–6289, 1993.
Shyy, Y.J., L.L. Wickman, J.P. Hagan, H.J. Hsieh, Y.L. Hu, S.H. Telian, A.J. Valente, K.L.P. Sung, and S. Chien. Human monocyte colony-stimulating factor stimulates the gene expression of monocyte chemotactic protein-1 and increases the adhesion of monocytes to endothelial monolayers. J. Clin. Invest., 92:1745–1751, 1993.
Sica, A., K. Matsushima, J. Van Damme, J.M. Wang, N. Polentarutti, E. Dejana, F. Colotta, and A. Mantovani. IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells. Immunology, 69:548–553, 1990a.
Sica, A., J.M. Wang, F. Colotta, E. Dejana, A. Mantovani, J.J. Oppenheim, C.G. Larsen, C.O. Zachariae, and K. Matushima. Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J. Immunol, 144:3034–3038, 1990b.
Siebenlist, U., G. Franzoso, and K. Brown. Structure, regulation and function of NF-kB. Annu. Rev. Cell Biol., 10:405–455, 1994.
Simantov, R., J.M. LaSala, S.K. Lo, A.E. Gharavi, L.R. Sammaritano, and J.E. Salmon. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J. Clin. Invest., 96:2211–2219, 1995.
Sironi, M., F. Breviario, P. Proserpio, A. Biondi, A. Vecchi, J. Van Damme, E. Dejana, and A. Mantovani. IL-1 stimulates IL-6 production in endothelial cells. J. Immunol., 142:549–553, 1989.
Sironi, M. C. Munoz, T. Pollicino, A. Siboni, F.L. Sciacca, S. Bernasconi, A. Vecchi, F. Colotta, and A. Mantovani. Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells. Eur. J. Immunol, 23:2692–2695, 1993.
Sironi, M., F.L. Sciacca, C. Matteucci, M. Conni, A. Vecchi, S. Bernasconi, A. Minty, D. Caput, P. Ferrara, F. Colotta, and A. Mantovani. Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. Blood, 84:1913–1921,1994.
Slowik, M.R., L.G. De Luca, W. Fiers, and J.S. Pober. Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration. Am. J. Pathol., 143:1724–1730, 1993.
Smith, W.B., J.R. Gamble, I. Clarklewis, and M.A. Vadas. Chemotactic desensitization of neutrophils demonstrates interleukin-8 (IL-8)-dependent and IL-8-independent mechanisms of transmigration through cytokine-activated endothelium. Immunology, 78:491–497, 1993.
Sporn, M.B., A.B. Roberts, L.M. Wakefield, and B. Crombrugghe. Some recent advances in the chemistry and biology of transforming growth factor-beta. J. Cell Biol., 105:1039–1045, 1987.
Strieter, R.M., S.L. Klunkel, H.J. Showell, D.G. Remick, S.H. Phan, P.A. Ward, and R.M. Marks. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. Science, 243:1467–1469, 1989.
Strieter, R.M., S.L. Klunkel, V.M. Einer, C.L. Martonyi, A.E. Koch, P.J. Polverini, and S.G. Einer. Interleukin-8. A corneal factor that induces neovascularization. Am. J. Pathol., 141:1279–1284, 1992.
Strieter, R.M., P.J. Polverini, S.L. Klunkel, D.A. Arenberg, M.D. Burdick, J. Kasper, J. Dzuiba, J. Van Damme, A. Walz, D. Marriott, S.Y. Chan, R. Roczniak, and A.B. Shanafelt. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem., 270:27348–27357, 1995.
Suen, Y., M. Chang, S.M. Lee, J.S. Buzby, and M.S. Cairo. Regulation of interleukin-11 protein and mRNA expression in neonatal and adult fibroblasts and endothelial cells. Blood, 84:4125–4134, 1994.
Suschek, C., H. Rothe, K. Fehsel, J. Enczmann, and V. Kolb Bachofen. Induction of a macrophage-like nitric oxide synthase in cultured rat aortic endothelial cells. IL-1 beta-mediated induction regulated by tumor necrosis factor-alpha and IFN-gamma. J. Immunol., 151:3283–3291, 1993.
Tachado, S.D., P. Gerold, M.J. McConville, T. Baldwin, D. Quilichi, R.T. Schwartz and L. Schofield. Glycosylphosphatiylinositol toxin of plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tryosine kinase-dependent and protein kinase C-dependent signaling pathway. J. Immunol., 156:1897–1907, 1996.
Takeya, M., T. Yoshimura, EJ. Leonard, and K. Takahashi. Detection of monocyte chemoattractant protein-1 in human athersclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum. Pathol., 24:534–539, 1993.
Tartaglia, L.A., D. Pennica, and D.V. Goeddel. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem., 268:18542–18548, 1993.
Thanos, D. and T. Maniatis. NF-kappa B: A lesson in family values. Cell, 80:529–532, 1995.
Tijan, R. and T. Maniatis. Transcriptional activation: a complex puzzle with few easy pieces. Cell, 77:5–8, 1994.
Valente, A.J., S.R. Fowler, E.A. Sprague, J.L. Kelley, C.A. Suenram, and C.J. Schwartz. Initial characterization of paripheral blood mononuclear cell chemoattractant derived from cultured arterial smooth muscle cells. Am. J. Pathol., 117:409–417, 1984.
Valente, A.J., D.A. Graves, C.E. Vialle-Valentin, R. Delgado, and C.J. Schwartz. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry, 27:4162–4168, 1988.
van der Kar, N.C., L.A. Monnens, M.A. Karmali, and V.W. van Hinsbergh. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. Blood, 81:2755–2764, 1992.
van der Kar, N.C., T. Kooistra, M. Vermeer, W. Lesslauer, L.A. Monnens, and V.W. van Hinsbergh. Tumor necrosis factor alpha induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C. Blood, 85:734–743, 1995.
van Hinsbergh, V.W., M. Vermeer, P. Koolwijk, J. Grimbergen, and T. Kooistra. Genistein reduces tumor necrosis factor alpha-induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells. Blood, 84:2984–2991, 1994.
Vidal Alles, V., B. Bottazzi, G. Peri, J. Golay, M. Introna, and A. Mantovani. Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes. Blood, 84:3483–3493, 1994.
Villarete, L.H. and D.G. Remick. Nitric oxide regulation of IL-8 expression in human endothelial cells. Biochem. Biophys. Res. Commun., 211:671–676, 1995.
Voest, E.E., B.M. Kenyon, M.S. O’Reilly, G. Truitt, R.J. D’Amato, and J. Folkman. Inhibition of angiongenesis in vivo by inerleukin-12. J. Natl. Cancer Inst., 87:581–586, 1995.
von Asmuth, E.J., M.A. Dentener, V. Bazil, M.G. Bouma, J.F. Leeuwenberg and W.A. Buurman. Anti-CD 14 antibodies reduce responses of cultured human endothelial cells to endotoxin. Immunology, 80:78–83, 1993.
von der Ahe, D., C. Nischan, C. Kunz, J. Otte, U. Knies, H. Oderwald, and B. Wasylyk. Ets transcription factor binding site is required for positive and TNF alpha-induced negative promoter regulation. Nucleic Acid Res., 21:5636–5643, 1993.
Vora, M., H. Yssel, J.E. de Vries, and M.A. Karasek. Antigen presentation by human dermal microvascular endothelial cells. Immunoregulatory effect of IFN-gamma and IL-10. J. Immunol, 152:5734–5741, 1994.
Wakabayashi, H., P.G. Cavanaugh, and G.L. Nicolson. Purification and identification of mouse lung microvessel endothelial cell-derived chemoattractant for lung metastasizing murine RAW117 large-cell lymphona cels: identification as mouse monocyte chemotactic protein 1. Cancer Res., 55:4458–4464, 1995.
Wang, J.M., G. Taraboletti, K. Matsushima, J. Van Damme, and A. Mantovani. Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8. Biochem. Biophys. Res. Commun., 169:165–170, 1990.
Wang, J.M., A. Sica, G. Peri, S. Walter, I.M. Padura, P. Libby, M. Ceska, I. Lindley, F. Colotta, and A. Mantovani. Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. Arterioscler. Thromb., 11:1166–1174, 1991.
Warner, S.J. and P. Libby. Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. J. Immunol., 142:100–109, 1989.
Weber, C., E. Negrescu, W. Erl, A. Pietsch, M. Frankenberger, H.W. Ziegler Heitbrock, W. Siess, and P.C. Weber. Inhibitors of protein tyrosine kinase suppress TNF-stimulated induction of endothelial cell adhesion molecules. J. Immunol., 155:445–451, 1995.
Wen, D., A. Rowland, and R. Derynck. Expression and secretion of gro/MGSA by stimulated human endothelial cells. EMBO J., 8:1761–1766, 1989.
Werner Felmayer, G., E.R. Werner, D. Fuchs, A. Hausen, G. Reibnegger, K. Schmidt, G. Weiss, and H. Wachter. Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. J. Biol Chem., 268:1842–1846, 1993.
Whelan, J., P. Ghersa, R. Hooft van Huijsduijnen, J. Gray, G. Chandra, F. Talabot, and J.F. DeLamarter. An NF kappa B-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Nucleic Acids Res., 19:2645–2653, 1991.
Whitley, M.Z. D. Thanos, M.A. Read, T. Maniatis, and T. Collins. A striking similarity in the organization of the E-selectin and beta interferon gene promoters. Mol. Cell Biol., 14:6464–6475, 1994.
Willimann, K., H. Matile, N.A. Weiss, and B.A. Imhof. In vivo sequestration of plasmodium falciparum-infected human erythrocytes: a severe combined immunodeficiency mouse model for cerebral malaria. J. Exp. Med., 182:643–653, 1995.
Wojta, J., M. Gallicchio, H. Zoellner, E.L. Filonzi, J.A. Hamilton, and K. Mcgrath. Interleukin-4 stimulates expression of urokinase-type-plasminogen activator in cultured human foreskin microvascular endothelial cells. Blood, 81:3285–3292, 1993.
Wolf, F.W., R.M. Marks, V. Sarma, M.G. Byers, R.W. Katz, T.B. Shows, and V.M. Dixit. Characterization of a novel tumor necrosis factor-alpha-induced endothelial primary response gene. J. Biol. Chem., 267:1317–1326, 1992.
Wolf, F.W., V. Sarma, M. Seldin, S. Drake, S.J. Suchard, H. Shao, K.S. O’Shea, and V.M. Dixit. B94, a primary response gene inducible by tumor necrosis factor-alpha, is expressed in developing hematopoietic tissues and the sperm acrosome. J. Biol. Chem., 269:3633–3640, 1994.
Woodroffe, S.B., H.M. Garnett, and J.E. Layton. Cytomegalovirus infection of vascular endothelial cells alters production of GM-CSF and G-CSF. Immunol. Cell Biol., 72:187–190, 1994.
Yan, S.F., I. Tritto, D. Pinsky, H. Liao, J. Huang, G. Fuller, J. Brett, L. May, and D. Stern. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. J. Biol. Chem., 270:11463–11471, 1995.
Yao, L., V. Bengualid, F.D. Lowy, J.J. Gibbons, V.B. Hatcher, and J.W. Berman. Internalization of staphylococcus aureus by endothelial cells induces cytokine gene expresssion. Infect. Immun., 63:1835–1839, 1995.
Yellin, M.J., J. Brett, D. Baum, A. Matsushima, A. Szabolcs, D. Stern, and L. Chess. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J. Exp. Med., 182:1857–1864, 1995.
Yla Herttuala, S., B.A. Lipton, M.E. Rosenfeld, T. Sarkioja, T. Yoshimura, E.J. Leonard, J.L. Witztum, and D. Steinberg. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. USA, 88:5252–5256, 1991.
Yoshizumi, M., M.A. Perella, J.C. Burnett, Jr., and M.E. Lee. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ. Res., 73:205–209, 1993.
Yu, X., S. Dluz, D.T. Graves, L. Zhang, H.N. Antoniades, W. Hollander, S. Prusty, A.J. Valente, C.J. Schwartz, and G.E. Sonenshein. Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates. Proc. Natl. Acad. Sci. USA, 89:6953–6957, 1992.
Zeiher, A.M., B. Fisslthaler, B. Schray Utz, and R. Busse. Nitric oxide modulates th expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ. Res., 76:980–986, 1995.
Zhang, R., W. Min, and W.C. Sessa. Functional analysis of the human endothelial nitric oxide synthase promoter. Sp1 and GATA factors are necessary for basal transcription in endothelial cells. J. Biol. Chem., 270:15320–15326, 1995.
Ziehe, M., L. Morbidelli, E. Masini, S. Amerini, H.J. Granger, C.A. Maggi, P. Geppetti, and F. Ledda. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest., 94:2036–2044, 1994.
Zoja, C., J.M. Wang, S. Bettoni, M. Sironi, D. Renzi, F. Chiaffarino, H.E. Abobud, J. Van Damme, A. Mantovani, G. Remuzzi, and A. Rambaldi. Interleukin-1 beta and tumor necrosis factor-alpha induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells. Am. J. Pathol, 138:991–1003, 1991.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mantovani, A., Allavena, P., Vecchi, A., Dejana, E., Sozzani, S., Introna, M. (1998). Cytokine Regulation of Endothelial Cell Function. In: Catravas, J.D., Callow, A.D., Ryan, U.S. (eds) Vascular Endothelium. NATO ASI Series, vol 294. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0133-0_9
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0133-0_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0135-4
Online ISBN: 978-1-4899-0133-0
eBook Packages: Springer Book Archive